Resorcinolnaphthalein
CAS No. 41307-63-5
Resorcinolnaphthalein ( —— )
Catalog No. M22438 CAS No. 41307-63-5
Resorcinolnaphthalein is a specific?enhancer of angiotensin-converting enzyme 2 (ACE2) (EC50 value of 19.5 μM). ACE2 activity in a dose-dependent manner enhanced by Resorcinolnaphthalein (100 μM) and XNT (EC50 values of 19.5 μM and 20.1 μM, respectively).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
10MG | 35 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameResorcinolnaphthalein
-
NoteResearch use only, not for human use.
-
Brief DescriptionResorcinolnaphthalein is a specific?enhancer of angiotensin-converting enzyme 2 (ACE2) (EC50 value of 19.5 μM). ACE2 activity in a dose-dependent manner enhanced by Resorcinolnaphthalein (100 μM) and XNT (EC50 values of 19.5 μM and 20.1 μM, respectively).
-
DescriptionResorcinolnaphthalein is a specific?enhancer of angiotensin-converting enzyme 2 (ACE2) (EC50 value of 19.5 μM). ACE2 activity in a dose-dependent manner enhanced by Resorcinolnaphthalein (100 μM) and XNT (EC50 values of 19.5 μM and 20.1 μM, respectively).ACE2 is an effective enzyme in attenuating fibrosis and structural remodeling. Enhancement of ACE2 activity has beneficial effects on the cardiovascular system and protects against hypertension induced pathophysiology.resorcinolnaphthalein enhanced ACE2 activity in a dose-dependent manner.?Acute in vivo administration of the xanthenone resulted in a dose-dependent transient and robust decrease in blood pressure (at 10 mg/kg, spontaneously hypertensive rats decreased 71+/-9 mm Hg and Wistar-Kyoto rats decreased 21+/-8 mm Hg;?P<0.05).?Chronic infusion of the xanthenone (120 microg/day) resulted in a modest decrease in the spontaneously hypertensive rat blood pressure (17 mm Hg;?2-way ANOVA;?P<0.05), whereas it had no effect in Wistar-Kyoto rats.?Strikingly, the decrease in blood pressure was also associated with improvements in cardiac function and reversal of myocardial, perivascular, and renal fibrosis in the spontaneously hypertensive rats.
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetRAAS
-
RecptorACE2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number41307-63-5
-
Formula Weight382.36
-
Molecular FormulaC24H14O5
-
Purity>98% (HPLC)
-
SolubilityDMSO : 120 mg/mL?(313.84 mM;?Need ultrasonic)
-
SMILESOc1ccc2c(Oc3cc(O)ccc3C22OC(=O)c3cccc4cccc2c34)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hernández Prada JA, et al.Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents.Hypertension. 2008 May;51(5):1312-7.
molnova catalog
related products
-
Voglibose
Voglibose, an N-substituted derivative of valiolamine, exhibits excellent inhibitory activity against α-glucosidases and action against hyperglycemia and various disorders caused by hyperglycemia.
-
ANGIOTENSIN IV TFA
ANGIOTENSIN IV TFA is a less effective agonist at the angiotensin AT1 receptor.
-
(-)-3,5-Dicaffeoyl q...
3,5-Dicaffeoylquinic acid is an isolated compound from Artemisia argyi; its ester derivatives exert anti-leucyl-tRNA synthetase of Giardia lamblia (GlLeuRS) and potential anti-giardial effects.